Marc E. Rothenberg, MD, PhD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Targeting Type 2 Inflammation

Please visit answersincme.com/WBE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in allergy and immunology discusses how new and emerging therapeutic options targeting type 2 inflammation can improve quality of life for patients with eosinophilic esophagitis (EoE). Upon completion of this activity, participants should be better able to: Recognize the therapeutic rationale for targeting type 2 inflammatory factors to treat EoE; and Outline individual approaches to optimize therapeutic regimens for patients with EoE.